ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Part of paid clinical trials in Newport Beach, California.
- Sponsor
- Edwards Lifesciences
- Study ID
- NCT05172973
- Status
- Recruiting
Conditions
- Aortic Valve Insufficiency
- Aortic Valve Stenosis
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SAPIEN X4 THV — DEVICEImplantation of the SAPIEN X4 valve
Study Details
The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve.
Key Dates
- Start date
- Nov 22, 2023
- Status verified
- May 2025
- Primary completion
- Dec 31, 2026
- Completion
- Feb 29, 2036
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Transcatheter Aortic Valve Replacement (TAVR) - Surgical ValveTAVR implant in subjects with a failing aortic surgical valve.
- Experimental: Transcatheter Aortic Valve Replacement (TAVR) - THVTAVR implant in subjects with a failing aortic transcatheter heart valve (THV).
Primary Outcome Measure
Non-hierarchical composite of death and stroke [ Time Frame: 1 year ]
Central Contacts
- Edwards THV Clinical Affairs949-250-2500
Locations (32)
Find similar trials in Newport Beach, CA
By research site
Hoag Memorial Hospital Presbyterian· Newport Beach, CABay Area Structural Heart at Sutter Health· San Francisco, CAKaiser San Francisco· San Francisco, CAStanford University Medical Center· Stanford, CAUC Health Medical Center of the Rockies· Loveland, CONaples Community Hospital Healthcare System· Naples, FL
Related Studies
- Imaging Histone Deacetylase in the HeartRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Transpacific TAVR RegistryRecruiting · Duk-Woo Park, MD · Stanford, California
- PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRRecruiting · Edwards Lifesciences · Huntsville, Alabama
- Effect of Fetal Aortic Valvuloplasty on OutcomesRecruiting · Queen Silvia Children's Hospital, Gothenburg, Sweden · San Francisco, California